AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

AMWL · NYSE · Medical - Healthcare Information Services

Amwell (AMWL)

Enterprise software for embedded hybrid healthcare delivery.

$13.37

vs last close+0.16 (+1.21%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	62	71	60	63	61	71	67	71	56	55	55	52
Cost of revenue	40	47	41	39	38	37	32	31	27	27	34	24
Gross profit	21	24	18	23	23	34	35	40	30	28	20	28
	165	81	93	76	70	77	66	60	59	53	33	37
Research & development	28	26	27	21	20	19	22	18	19	14	12	10
	50	46	58	47	42	50	36	34	31	31	25	20
Selling & marketing	20	22	26	18	17	15	13	13	9	9	8	6
General & administrative	30	24	33	28	25	35	23	21	22	22	18	14
Other expenses	87	8	8	8	8	8	8	8	9	8	−4	7
Operating income	−143	−57	−75	−52	−47	−43	−30	−20	−29	−25	−13	−10
	7	7	3	2	3	0	13	0	−1	−1	3	−1
Interest income	8	8	4	3	4	0	3	1	1	0	0	0
Interest expense	0	0	0	0	0	0	0	0	0	0	0	1
Other non-operating income	−79	−7	−3	−2	−3	0	−13	0	1	1	−3	1
Income before tax	−136	−49	−72	−50	−44	−43	−18	−20	−31	−26	−10	−10
Income tax expense	1	1	1	0	0	2	1	−1	1	−1	0	−1
Net income from continuing operations	−137	−50	−73	−51	−44	−45	−18	−20	−32	−25	−10	−10
Other adjustments	0	0	0	0	0	0	0	0	0	0	0	−1
Net income	−136	−49	−72	−50	−43	−43	−19	−20	−32	−25	−11	−10
EPS, basic	−$9.54	−$3.37	−$4.93	−$3.36	−$2.87	−$2.77	−$1.19	−$1.24	−$2.00	−$1.52	−$0.66	−$0.59
EPS, diluted	−$9.54	−$3.37	−$4.93	−$3.36	−$2.87	−$2.77	−$1.19	−$1.24	−$2.00	−$1.52	−$0.66	−$0.59
Weighted average shares, basic	14	14	15	15	15	15	16	16	16	16	17	17
Weighted average shares, diluted	14	14	15	15	15	15	16	16	16	16	17	17
EBITDA	−56	−41	−64	−42	−36	−35	−10	−12	−21	−17	−2	−3
Depreciation & amortization	8	8	8	8	8	8	8	8	9	8	8	7
EBIT	−64	−49	−72	−50	−44	−43	−18	−20	−31	−26	−10	−10